August 2023 in “Annales de Dermatologie et de Vénéréologie” This review analyzed data from 237 patients across 27 publications to provide an updated overview of non-scarring alopecia (NSA) in lupus erythematosus (LE) patients. It found that diffuse/patchy NSA and lupus hair are strongly associated with systemic LE activity, show subtle signs of inflammation, and typically respond well to SLE therapy without progressing to scarring alopecia. In contrast, NSA associated with dermal cutaneous LE or lupus panniculitis of the scalp is less commonly linked to SLE and responds better to skin-directed therapies. The study suggests that diffuse/patchy NSA and lupus hair may be variations of a single LE-specific entity and calls for prospective studies to further explore this manifestation.
32 citations,
September 1989 in “Medical Clinics of North America” Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.
4 citations,
January 2012 in “Elsevier eBooks” The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.
1 citations,
January 2010 in “Elsevier eBooks” Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.
21 citations,
September 2015 in “Journal of the European Academy of Dermatology and Venereology” Yellow and orange colors are important for diagnosing certain skin conditions.